Arkolith/Insider Trading/RUBY/Form 4

Epstein David R

DirectorRubius Therapeutics, Inc. (RUBY) · full profile →Form 4 · filed Apr 22, 2022
Net Buying
Open-Market Buys
$43K
Open-Market Sells
$0
Net Open-Market Flow
$43K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 21, 2022Buy(P)30K$1.44$43K4.7M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001179110-22-002716) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML